Patents Assigned to Nemours Foundation
-
Patent number: 12247213Abstract: Provided herein are gene therapy methods for the treatment of mucopolysaccharidosis type IVA (MPS IVA) involving the use of recombinant adeno-associated viruses (rAAVs) to deliver human N-acetylgalactosamine-6-sulfate sulfatase (hGALNS) to the bone of a human subject diagnosed with MPS IVA. Also provided herein are rAAVs that can be used in the gene therapy methods and methods of making such rAAVs.Type: GrantFiled: July 26, 2019Date of Patent: March 11, 2025Assignees: THE NEMOURS FOUNDATION, REGENXBIO INC.Inventors: Shunji Tomatsu, Kazuki Sawamoto, Subha Karumuthil-Melethil, Olivier Danos
-
Publication number: 20240091285Abstract: A pharmaceutical composition for treatment of a tumor expressing at least one of a plurality of receptor proteins including CD24, Axl, DC-SIGN, Tyro3, MER, MerTK TIM-1, TIM-4, TLR3, TLR8, RIG-1, and MDA5. The pharmaceutical composition includes either a purified viral RNA of an oncolytic Zika virus in a liposome and a pharmaceutically acceptable carrier, or a pharmaceutically acceptable carrier and a unit dosage form of an oncolytic Zika virus.Type: ApplicationFiled: September 15, 2023Publication date: March 21, 2024Applicant: THE NEMOURS FOUNDATIONInventors: Kenneth Andrew ALEXANDER, Rajarajeshwari VENKATARAMAN, Peter Eugene PHELAN, III
-
Publication number: 20230310247Abstract: A head cradle for supporting a head of a patient during surgery when the patient is in a prone position. The head cradle includes a structural member with a body having a concave profile, a first end and a second end. The body has a forehead portion positioned at the first end for supporting a forehead of a patient and at least one cheek portion for supporting a cheek of the patient. The body includes an aperture defined through the structural member adjacent to the forehead portion between the first end and the second end. The structural member is sized to terminate at a position at or superior to a chin of the patient. A support member is provided to be received by the structural member and to interface with at least a portion of a face of the patient.Type: ApplicationFiled: March 9, 2023Publication date: October 5, 2023Applicant: The Nemours FoundationInventors: Phoebe FISHER, Tariq RAHMAN, Jinyong WEE
-
Patent number: 11628239Abstract: Skeletonized blood vessels for use as vascular grafts are protected from biomechanical injury and/or certain cellular and extracellular changes by application of a biocompatible hydrogel to the vessel exterior. The hydrogel may be applied to the vessel graft before or after harvesting from a donor patient.Type: GrantFiled: November 3, 2017Date of Patent: April 18, 2023Assignees: University of Delaware, The Nemours FoundationInventors: Robert Akins, Kristi L. Kiick, Karyn Robinson, Rebecca Scott
-
Patent number: 11484459Abstract: An elbow joint boost device has first and second frames to be attached to the forearm and lower arm of a patient. A guide mounted on the first frame extends generally along the respective one of the forearm and upper arm. A link is mounted on the guide for sliding movement along the guide, and a spring acts in tension between the sliding link and a point on the second frame remote from the patient's elbow. As the patient straightens and bends the elbow, the link can slide along the guide, varying the leverage of the tension spring.Type: GrantFiled: May 11, 2020Date of Patent: November 1, 2022Assignee: THE NEMOURS FOUNDATIONInventors: Tariq Rahman, Jinyong Wee
-
Patent number: 11384156Abstract: A chimeric antigen receptor specific for the extracellular membrane-proximal domain (EMPD) of membrane-bound IgE (mIgE) is provided. The EMPD-specific chimeric antigen receptor comprises an extracellular ligand binding domain capable of binding EMPD, a transmembrane domain, and an intracellular domain that mediates T cell activation upon EMPD binding. Nucleic acids and vectors encoding the EMPD-specific chimeric antigen receptor are provided. T cells transduced with such vectors find use in chimeric antigen receptor-based adoptive T-cell therapy for targeting IgE-expressing B cells and treating IgE-mediated allergic diseases.Type: GrantFiled: July 17, 2017Date of Patent: July 12, 2022Assignee: THE NEMOURS FOUNDATIONInventor: Zhengyu Ma
-
Publication number: 20220125846Abstract: Provided are tumor-activated alloreactive or xenoreactive T cells that are active only at the tumor sites and methods for the generation of tumor-activated alloreactive or xenoreactive T cells. Also provided are methods for using these tumor-activated alloreactive or xenoreactive T cells to treat tumors and cancers. The alloreactivity or xenoreactivity of the T cells at the tumor sites leads to the killing of tumor cells and stromal cells that express mismatched HLA molecules. The lack of activity of these T cells at non-tumor locations prevents attack on normal tissues. Further related methods and products are provided.Type: ApplicationFiled: January 12, 2022Publication date: April 28, 2022Applicant: THE NEMOURS FOUNDATIONInventor: Zhengyu MA
-
Patent number: 11234640Abstract: Objective Pulmonary Function (PF) evaluation for respiratory fatigue is vital to the diagnosis and management of many pediatric respiratory diseases in the intensive care, emergency and outpatient settings. A non-invasive PF instrument utilizes sensors and software to access respiratory breathing patterns, vital parameters, asynchrony and measures the work of breathing. Software algorithms predict respiratory fatigue. The hardware includes a microcircuit board that individually links to rib cage (RC) and abdominal (ABD) inductance bands. The bands wirelessly transmit changes in RC and ABD circumference. Point-of-care, real-time indices of respiratory work, breathing patterns and respiratory fatigue indices are developed on a user-friendly graphical user interface. The diagnostic data can later be securely emailed as an attachment for entry into patients' electronic medical records or sent to a caretaker's computer, or used directly to control a respiratory therapy device.Type: GrantFiled: June 27, 2018Date of Patent: February 1, 2022Assignee: THE NEMOURS FOUNDATIONInventors: Tariq Rahman, Thomas H. Shaffer, Ralph Page, Jean Remy Bonnefoy, Christopher Page
-
Publication number: 20210322495Abstract: CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.Type: ApplicationFiled: May 3, 2021Publication date: October 21, 2021Applicant: THE NEMOURS FOUNDATIONInventors: Kenneth Andrew ALEXANDER, Terri Helman FINKEL, Joseph MAZAR, Amy Lynn ROSADO, Jiangfang WANG, Tamarah Jeanette WESTMORELAND
-
Publication number: 20200206323Abstract: A therapeutic agent containing, as an effective component, a glycolytic enzyme which is different from a deficient protein of a patient with lysosomal storage disease as a subject and/or a glycolytic enzyme which does not have a mannose 6-phosphate moiety or a mannose moiety.Type: ApplicationFiled: September 7, 2018Publication date: July 2, 2020Applicants: THE NEMOURS FOUNDATION, SEIKAGAKU CORPORATIONInventors: Shunji TOMATSU, Kazuki SAWAMOTO, Takehiko NAKAMURA, Ikue KITAZAWA, Hideyuki FUTATSUMORI
-
Publication number: 20200165675Abstract: In one aspect, the invention provides a method of detecting cerebral palsy in a subject. The method includes: determining a methylation state for each of a plurality of cytosine-guanine dinucleotide (CpG) sites in a sample obtained from the subject, calculating a differential methylation level based on the methylation states of the plurality of CpG sites, and comparing the differential methylation level to a predetermined reference level. When the differential methylation level deviates from the predetermined reference level, the presence of cerebral palsy is indicated in the patient.Type: ApplicationFiled: May 31, 2018Publication date: May 28, 2020Applicants: Genome Profiling, LLC, The Nemours FoundationInventors: Adam G. Marsh, Robert E. Akins, JR., Erin L. Crowgey, Karyn G. Robinson
-
Publication number: 20200061244Abstract: Skeletonized blood vessels for use as vascular grafts are protected from biomechanical injury and/or certain cellular and extracellular changes by application of a biocompatible hydrogel to the vessel exterior. The hydrogel may be applied to the vessel graft before or after harvesting from a donor patient.Type: ApplicationFiled: November 3, 2017Publication date: February 27, 2020Applicants: University of Delaware, The Nemours FoundationInventors: Robert AKINS, Kristi L. Kiick, Karyn ROBINSON, Rebecca SCOTT
-
Publication number: 20190038685Abstract: CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.Type: ApplicationFiled: August 6, 2018Publication date: February 7, 2019Applicant: THE NEMOURS FOUNDATIONInventors: Kenneth Andrew ALEXANDER, Terri Helman FINKEL, Joseph MAZAR, Amy Lynn ROSADO, Jiangfang WANG, Tamarah Jeanette WESTMORELAND
-
Patent number: 10195272Abstract: A chimeric antigen receptor (CAR) contains a human Fc?RI? extracellular domain or a mutant Fc?RI? extracellular domain that has a reduced binding affinity for human IgE compared to wild type human Fc?RI? extracellular domain. The CAR further contains an intracellular signaling domain comprising at least one immunoreceptor-based activation motif (ITAM). The CAR may further comprise a costimulatory signaling domain, such as an intracellular domain of at least one of the costimulatory molecules 4-1BB, CD27, CD28, CD134 or ICOS. T cells transduced with vectors encoding the CAR are used in CAR-based adoptive T-cell therapy for targeting IgE-expressing B cells and treating IgE-mediated allergic diseases.Type: GrantFiled: March 29, 2016Date of Patent: February 5, 2019Assignee: The Nemours FoundationInventor: Zhengyu Ma
-
Publication number: 20180267019Abstract: An assay mixture includes a hydrogel of a shear-thinning ?-hairpin peptide, a plurality of cells, and one or more predetermined compounds being investigated for ability to affect the growth, viability, reproduction characteristics, or activity of the cells. A high throughput screening device includes a plurality of sample wells adapted for high throughput screening, wherein each well contains the assay mixture. A method of using the high throughput screening device includes a) depositing in each of the wells a ?-hairpin hydrogel including the cells; depositing in at least some of the wells one or more of the compounds, either along with the ?-hairpin hydrogel or separately; and c) measuring the growth, viability, reproduction characteristics, or activity of the cells in each of the plurality of wells.Type: ApplicationFiled: September 23, 2016Publication date: September 20, 2018Applicants: UNIVERSITY OF DELAWARE, THE NEMOURS FOUNDATIONInventors: Sigrid A. LANGHANS, Darrin J. POCHAN, Peter WORTHINGTON, Andrew D. NAPPER
-
Patent number: 10064614Abstract: A retractor for use in lingual frenotomy has a tapered hollow shield, having a closed distal end and an open proximal rim, a groove opening through the distal end to seat over the lingual frenulum, and a handle extending from the proximal rim in line with the groove.Type: GrantFiled: March 18, 2015Date of Patent: September 4, 2018Assignee: THE NEMOURS FOUNDATIONInventors: Neil Nghia Tran, Tariq Rahman, Thomas H. Shaffer, Jordan Wang, Whitney Sample
-
Patent number: 9982288Abstract: Provided is a rapid screening method for detecting mucopolysaccharidosis IVA and mucopolysaccharidosis VII. Biological samples containing glycosaminoglycans are enzymatically digested to converts chondroitin 6-sulfate into ?Di-6S. ?Di-6S is assayed by liquid chromatography-tandem mass spectroscopy analysis. Elevated ?Di-6S, and thus elevated chondroitin 6-sulfate present in the sample, indicates a likelihood that the test subject is afflicted with mucopolysaccharidosis IVA or mucopolysaccharidosis VII.Type: GrantFiled: April 30, 2015Date of Patent: May 29, 2018Assignee: THE NEMOURS FOUNDATIONInventors: Tsutomu Shimada, Shunji Tomatsu
-
Patent number: 9687415Abstract: Systems and methods for assisting respiration extrathoracically, particularly useful for augmenting respiration in neonatal patients, including providing a positive pressure to a torso area of a patient. The positive pressure may be delivered to the torso area of the patient while the torso area is exposed to an ambient pressure, such as by providing positive pressure with high frequency gas jets that are positioned in proximity to the torso area. The positive pressure may be delivered to different parts of the torso area of the patient at different times, such as by controlling gas jets independently. The positive pressure may also be controlled in coordination with a gas flow and concentration to the patient's airway, such as by increasing the positive pressure as a gas flow pressure delivered to the patient's airway is reduced.Type: GrantFiled: May 13, 2011Date of Patent: June 27, 2017Assignee: THE NEMOURS FOUNDATIONInventors: Tariq Rahman, Thomas H. Shaffer, Marla R. Wolfson
-
Publication number: 20160287427Abstract: A gravity-balance device, which may be an orthotic support, has a support, a lever pivotally mounted on the support, a spring extending from the support to the lever, and a cam mounted on one of the lever and the support. The cam is positioned so that the spring wraps round the cam as the lever pivots, altering the effective point of action of the spring. A thing being supported can hang from the lever. The thing may be a sling supporting a human arm parallel to the lever, so that the spring compensates for the weight of the arm as the arm is raised and lowered. The cam may be a smooth curve, a polygon, or a row of pins at the corners of an imaginary polygon.Type: ApplicationFiled: March 29, 2016Publication date: October 6, 2016Applicant: The Nemours FoundationInventor: Tariq Rahman
-
Patent number: D751197Type: GrantFiled: March 18, 2014Date of Patent: March 8, 2016Assignee: The Nemours FoundationInventors: Neil Nghia Tran, Tariq Rahman, Thomas H. Shaffer, Jordan Wang, Whitney Sample